ID

38240

Description

HylaCare in the Treatment of Acute Skin Changes in Patients Undergoing Radiotherapy for Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02165605

Link

https://clinicaltrials.gov/show/NCT02165605

Keywords

  1. 10/1/19 10/1/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

October 1, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Breast Cancer NCT02165605

Eligibility Breast Cancer NCT02165605

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
female, age 18 or older
Description

Gender | Age

Data type

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
diagnosis of breast cancer
Description

Breast Carcinoma

Data type

boolean

Alias
UMLS CUI [1]
C0678222
intact breast (not surgically absent)
Description

Breast Intact

Data type

boolean

Alias
UMLS CUI [1,1]
C0006141
UMLS CUI [1,2]
C0205266
planned fractionated external beam radiotherapy to be delivered by opposing, tangential beams to 50.4 gy in 28 fractions with a planned photon or electron boost of 10gy in 5 fractions (for a total of 33 fractions)
Description

Teleradiotherapy Fractionated

Data type

boolean

Alias
UMLS CUI [1,1]
C0419095
UMLS CUI [1,2]
C1979893
ability to understand and comply with the requirements of this study
Description

Comprehension Study Protocol | Protocol Compliance

Data type

boolean

Alias
UMLS CUI [1,1]
C0162340
UMLS CUI [1,2]
C2348563
UMLS CUI [2]
C0525058
ability to give informed consent
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
for sexually active females, patient agrees to use acceptable method of birth control
Description

Gender Sexually active Contraceptive methods

Data type

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0241028
UMLS CUI [1,3]
C0700589
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
women who are pregnant or lactating
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
use of concomitant skin care preparations at any of the treated or control portal areas to be observed
Description

Skin Care Preparations Portal triad area

Data type

boolean

Alias
UMLS CUI [1,1]
C0150773
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0734842
any infection or unhealed wound of the radiotherapy portal areas, or generalized dermatitis
Description

Communicable Disease Therapeutic radiology procedure Portal triad area | Non-healed wound Therapeutic radiology procedure Portal triad area | Generalized dermatitis

Data type

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C1522449
UMLS CUI [1,3]
C0734842
UMLS CUI [2,1]
C0750433
UMLS CUI [2,2]
C1522449
UMLS CUI [2,3]
C0734842
UMLS CUI [3]
C0262995
severe renal failure creatinine > 3.0 within 6 months of study registration
Description

Kidney Failure Severe | Creatinine measurement, serum

Data type

boolean

Alias
UMLS CUI [1,1]
C0035078
UMLS CUI [1,2]
C0205082
UMLS CUI [2]
C0201976
allergic history, including anaphylaxis or severe allergies to products in study serum or placebo
Description

Patient allergic history | Anaphylaxis | Severe allergy Investigational New Drugs | Severe allergy Placebo products

Data type

boolean

Alias
UMLS CUI [1]
C3841443
UMLS CUI [2]
C0002792
UMLS CUI [3,1]
C2945656
UMLS CUI [3,2]
C0013230
UMLS CUI [4,1]
C2945656
UMLS CUI [4,2]
C1696465
UMLS CUI [4,3]
C1514468
planned relocation which would make follow-up visits impossible during the course of the study
Description

Relocation of home Planned | Follow-up visit Unsuccessful

Data type

boolean

Alias
UMLS CUI [1,1]
C2699029
UMLS CUI [1,2]
C1301732
UMLS CUI [2,1]
C0589121
UMLS CUI [2,2]
C1272705
collagen vascular disease such as lupus, or scleroderma
Description

Collagen-vascular disease | Lupus Erythematosus | Scleroderma

Data type

boolean

Alias
UMLS CUI [1]
C0262428
UMLS CUI [2]
C0409974
UMLS CUI [3]
C0011644

Similar models

Eligibility Breast Cancer NCT02165605

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Age
Item
female, age 18 or older
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Breast Carcinoma
Item
diagnosis of breast cancer
boolean
C0678222 (UMLS CUI [1])
Breast Intact
Item
intact breast (not surgically absent)
boolean
C0006141 (UMLS CUI [1,1])
C0205266 (UMLS CUI [1,2])
Teleradiotherapy Fractionated
Item
planned fractionated external beam radiotherapy to be delivered by opposing, tangential beams to 50.4 gy in 28 fractions with a planned photon or electron boost of 10gy in 5 fractions (for a total of 33 fractions)
boolean
C0419095 (UMLS CUI [1,1])
C1979893 (UMLS CUI [1,2])
Comprehension Study Protocol | Protocol Compliance
Item
ability to understand and comply with the requirements of this study
boolean
C0162340 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C0525058 (UMLS CUI [2])
Informed Consent
Item
ability to give informed consent
boolean
C0021430 (UMLS CUI [1])
Gender Sexually active Contraceptive methods
Item
for sexually active females, patient agrees to use acceptable method of birth control
boolean
C0079399 (UMLS CUI [1,1])
C0241028 (UMLS CUI [1,2])
C0700589 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
women who are pregnant or lactating
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Skin Care Preparations Portal triad area
Item
use of concomitant skin care preparations at any of the treated or control portal areas to be observed
boolean
C0150773 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0734842 (UMLS CUI [1,3])
Communicable Disease Therapeutic radiology procedure Portal triad area | Non-healed wound Therapeutic radiology procedure Portal triad area | Generalized dermatitis
Item
any infection or unhealed wound of the radiotherapy portal areas, or generalized dermatitis
boolean
C0009450 (UMLS CUI [1,1])
C1522449 (UMLS CUI [1,2])
C0734842 (UMLS CUI [1,3])
C0750433 (UMLS CUI [2,1])
C1522449 (UMLS CUI [2,2])
C0734842 (UMLS CUI [2,3])
C0262995 (UMLS CUI [3])
Kidney Failure Severe | Creatinine measurement, serum
Item
severe renal failure creatinine > 3.0 within 6 months of study registration
boolean
C0035078 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0201976 (UMLS CUI [2])
Patient allergic history | Anaphylaxis | Severe allergy Investigational New Drugs | Severe allergy Placebo products
Item
allergic history, including anaphylaxis or severe allergies to products in study serum or placebo
boolean
C3841443 (UMLS CUI [1])
C0002792 (UMLS CUI [2])
C2945656 (UMLS CUI [3,1])
C0013230 (UMLS CUI [3,2])
C2945656 (UMLS CUI [4,1])
C1696465 (UMLS CUI [4,2])
C1514468 (UMLS CUI [4,3])
Relocation of home Planned | Follow-up visit Unsuccessful
Item
planned relocation which would make follow-up visits impossible during the course of the study
boolean
C2699029 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
C0589121 (UMLS CUI [2,1])
C1272705 (UMLS CUI [2,2])
Collagen-vascular disease | Lupus Erythematosus | Scleroderma
Item
collagen vascular disease such as lupus, or scleroderma
boolean
C0262428 (UMLS CUI [1])
C0409974 (UMLS CUI [2])
C0011644 (UMLS CUI [3])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial